Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
van Karnebeek, Clara D.M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
13 |
|---|
| Übergeordnetes Werk: |
Enthalten in: NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS - Patterson, Tiffany ELSEVIER, 2016, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:65 ; year:2016 ; pages:1-13 ; extent:13 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.pediatrneurol.2016.07.010 |
|---|
| Katalog-ID: |
ELV024621870 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV024621870 | ||
| 003 | DE-627 | ||
| 005 | 20230623174418.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pediatrneurol.2016.07.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016015000027.pica |
| 035 | |a (DE-627)ELV024621870 | ||
| 035 | |a (ELSEVIER)S0887-8994(16)30195-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 600 |a 690 |q VZ |
| 084 | |a 51.00 |2 bkl | ||
| 084 | |a 51.32 |2 bkl | ||
| 100 | 1 | |a van Karnebeek, Clara D.M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| 264 | 1 | |c 2016 | |
| 300 | |a 13 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. | ||
| 650 | 7 | |a neurogenetic disorders |2 Elsevier | |
| 650 | 7 | |a genetic diseases |2 Elsevier | |
| 650 | 7 | |a therapy |2 Elsevier | |
| 650 | 7 | |a fragile X syndrome |2 Elsevier | |
| 650 | 7 | |a developmental disorders |2 Elsevier | |
| 700 | 1 | |a Bowden, Kristin |4 oth | |
| 700 | 1 | |a Berry-Kravis, Elizabeth |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Patterson, Tiffany ELSEVIER |t NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |d 2016 |g Amsterdam [u.a.] |w (DE-627)ELV01421802X |
| 773 | 1 | 8 | |g volume:65 |g year:2016 |g pages:1-13 |g extent:13 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.pediatrneurol.2016.07.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
| 936 | b | k | |a 51.32 |j Werkstoffmechanik |q VZ |
| 951 | |a AR | ||
| 952 | |d 65 |j 2016 |h 1-13 |g 13 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k c d v kcd kcdv |
|---|---|
| matchkey_str |
vankarnebeekclaradmbowdenkristinberrykra:2016----:ramnonuoeeidvlpetlodtosr |
| hierarchy_sort_str |
2016 |
| bklnumber |
51.00 51.32 |
| publishDate |
2016 |
| allfields |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
| spelling |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
| allfields_unstemmed |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
| allfieldsGer |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
| allfieldsSound |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
| language |
English |
| source |
Enthalten in NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS Amsterdam [u.a.] volume:65 year:2016 pages:1-13 extent:13 |
| sourceStr |
Enthalten in NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS Amsterdam [u.a.] volume:65 year:2016 pages:1-13 extent:13 |
| format_phy_str_mv |
Article |
| bklname |
Werkstoffkunde: Allgemeines Werkstoffmechanik |
| institution |
findex.gbv.de |
| topic_facet |
neurogenetic disorders genetic diseases therapy fragile X syndrome developmental disorders |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
| authorswithroles_txt_mv |
van Karnebeek, Clara D.M. @@aut@@ Bowden, Kristin @@oth@@ Berry-Kravis, Elizabeth @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV01421802X |
| dewey-sort |
3610 |
| id |
ELV024621870 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024621870</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174418.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016015000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024621870</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-8994(16)30195-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.32</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Karnebeek, Clara D.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurogenetic disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">genetic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">fragile X syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">developmental disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bowden, Kristin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry-Kravis, Elizabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Patterson, Tiffany ELSEVIER</subfield><subfield code="t">NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01421802X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:1-13</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.32</subfield><subfield code="j">Werkstoffmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">1-13</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
van Karnebeek, Clara D.M. |
| spellingShingle |
van Karnebeek, Clara D.M. ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| authorStr |
van Karnebeek, Clara D.M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV01421802X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 600 - Technology 690 - Buildings |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier |
| topic |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
| topic_unstemmed |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
| topic_browse |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k b kb e b k ebk |
| hierarchy_parent_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
| hierarchy_parent_id |
ELV01421802X |
| dewey-tens |
610 - Medicine & health 600 - Technology 690 - Building & construction |
| hierarchy_top_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV01421802X |
| title |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| ctrlnum |
(DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 |
| title_full |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| author_sort |
van Karnebeek, Clara D.M. |
| journal |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
| journalStr |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
van Karnebeek, Clara D.M. |
| container_volume |
65 |
| physical |
13 |
| class |
610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
van Karnebeek, Clara D.M. |
| doi_str_mv |
10.1016/j.pediatrneurol.2016.07.010 |
| dewey-full |
610 600 690 |
| title_sort |
treatment of neurogenetic developmental conditions: from 2016 into the future |
| title_auth |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| abstract |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
| abstractGer |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
| abstract_unstemmed |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 |
| title_short |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
| url |
https://doi.org/10.1016/j.pediatrneurol.2016.07.010 |
| remote_bool |
true |
| author2 |
Bowden, Kristin Berry-Kravis, Elizabeth |
| author2Str |
Bowden, Kristin Berry-Kravis, Elizabeth |
| ppnlink |
ELV01421802X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.pediatrneurol.2016.07.010 |
| up_date |
2024-07-06T21:55:03.887Z |
| _version_ |
1803868337747263488 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024621870</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174418.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016015000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024621870</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-8994(16)30195-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.32</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Karnebeek, Clara D.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurogenetic disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">genetic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">fragile X syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">developmental disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bowden, Kristin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry-Kravis, Elizabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Patterson, Tiffany ELSEVIER</subfield><subfield code="t">NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01421802X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:1-13</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.32</subfield><subfield code="j">Werkstoffmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">1-13</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4005013 |